APIMEDS PHARMACEUTICALS US, INC. (APUS) Free cash flow
APIMEDS PHARMACEUTICALS US, INC. (APUS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.0MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More APUS financial trends
APUS RevenueAPUS Net incomeAPUS Net marginAPUS Gross profitAPUS Gross marginAPUS Operating incomeAPUS Operating marginAPUS Operating cash flowAPUS Capital expendituresAPUS Return on equityAPUS Stock buybacksAPUS Dividends paidAPUS Total assetsAPUS Total liabilitiesAPUS Shareholders’ equityAPUS overview →